Patents by Inventor Sonjoy Mukerjee

Sonjoy Mukerjee has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7829677
    Abstract: The invention relates to antibodies that bind to antigens, such as antigens associated with hyperproliferating cells, and methods of treating hyperproliferative disorders. The invention antibodies are useful for treating hyperproliferative disorders, such as neoplasia.
    Type: Grant
    Filed: September 25, 2008
    Date of Patent: November 9, 2010
    Assignee: Shantha West, Inc.
    Inventors: Subhra Chakrabarti, Sonjoy Mukerjee, Mark C. Glassy
  • Publication number: 20090087442
    Abstract: The invention relates to antibodies that bind to antigens, such as antigens associated with hyperproliferating cells, and methods of treating hyperproliferative disorders. The invention antibodies are useful for treating hyperproliferative disorders, such as neoplasia.
    Type: Application
    Filed: September 25, 2008
    Publication date: April 2, 2009
    Inventors: Subhra Chakrabarti, Sonjoy Mukerjee, Mark C. Glassy
  • Patent number: 7446178
    Abstract: The invention relates to antibodies that bind to antigens, such as antigens associated with hyperproliferating cells, and methods of treating hyperproliferative disorders. The invention antibodies are useful for treating hyperproliferative disorders, such as neoplasia.
    Type: Grant
    Filed: December 6, 2006
    Date of Patent: November 4, 2008
    Assignee: Shantha West, Inc.
    Inventors: Subhra Chakrabarti, Sonjoy Mukerjee, Mark C. Glassy
  • Publication number: 20070280879
    Abstract: The antigen recognized by RM1 antibody is used for therapy, diagnosis and imaging.
    Type: Application
    Filed: March 11, 2005
    Publication date: December 6, 2007
    Applicant: Shantha West, Inc.
    Inventors: Mark Glassy, Michael McKnight, Sonjoy Mukerjee, Subhra Chakrabarti
  • Patent number: 7238353
    Abstract: The invention relates to antibodies that bind to antigens, such as antigens associated with hyperproliferating cells, and methods of treating hyperproliferative disorders. The invention antibodies are useful for treating hyperproliferative disorders, such as neoplasia.
    Type: Grant
    Filed: September 11, 2003
    Date of Patent: July 3, 2007
    Assignee: Shantha West, Inc.
    Inventors: Subhra Chakrabarti, Sonjoy Mukerjee, Mark C. Glassy
  • Publication number: 20070092443
    Abstract: The invention relates to antibodies that bind to antigens, such as antigens associated with hyperproliferating cells, and methods of treating hyperproliferative disorders. The invention antibodies are useful for treating hyperproliferative disorders, such as neoplasia.
    Type: Application
    Filed: December 6, 2006
    Publication date: April 26, 2007
    Applicant: SHANTHA WEST, INC.
    Inventors: Subhra Chakrabarti, Sonjoy Mukerjee, Mark Glassy
  • Publication number: 20050031621
    Abstract: The invention relates to antibodies that bind to antigens, such as antigens associated with hyperproliferating cells, and methods of treating hyperproliferative disorders. The invention antibodies are useful for treating hyperproliferative disorders, such as neoplasia.
    Type: Application
    Filed: September 11, 2003
    Publication date: February 10, 2005
    Inventors: Subhra Chakrabarti, Sonjoy Mukerjee, Mark Glassy
  • Patent number: 5744585
    Abstract: A human monoclonal antibody TB2A36C3 which shows high specificity against lung tumor antigens is described. TB2A36C3 can be used clinically for immunotherapy.
    Type: Grant
    Filed: March 16, 1995
    Date of Patent: April 28, 1998
    Inventors: Rajko D. Medenica, Sonjoy Mukerjee